Organon & Co

OGN · Moat type: REGULIERUNG

MoatScore

3/10

Fair Value

31 USD

Margin of Safety

+56.0 %

Rating

BEOBACHTEN

Organon & Co (OGN) is a pharmaceutical company specializing in women's health, biosimilars, and established branded pharmaceuticals, which generates its revenue primarily through patented and off-patent medications and a growing biosimilar portfolio across more than 140 markets worldwide.

View full analysis →

🔒 Detailed AI analysis, peer comparison, capital allocation, crisis resilience & PDF report for Pro members.

Not investment advice. Analyses are research, not a recommendation. Valuations may be erroneous or incomplete. © MoatScan.ai — proprietary methodology.